Econ Financial Services Corp Increases Position in HealthEquity, Inc. $HQY

Econ Financial Services Corp lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 39.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 27,249 shares of the company’s stock after buying an additional 7,770 shares during the period. Econ Financial Services Corp’s holdings in HealthEquity were worth $2,496,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its stake in HealthEquity by 2.9% during the 3rd quarter. Vanguard Group Inc. now owns 8,746,255 shares of the company’s stock valued at $828,883,000 after acquiring an additional 243,549 shares during the last quarter. Wasatch Advisors LP lifted its position in HealthEquity by 3.4% during the 3rd quarter. Wasatch Advisors LP now owns 6,307,675 shares of the company’s stock worth $597,778,000 after acquiring an additional 206,611 shares during the period. AQR Capital Management LLC grew its stake in shares of HealthEquity by 59.3% in the 3rd quarter. AQR Capital Management LLC now owns 1,764,268 shares of the company’s stock valued at $167,200,000 after purchasing an additional 656,820 shares during the last quarter. Westfield Capital Management Co. LP grew its stake in shares of HealthEquity by 35.7% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock valued at $162,688,000 after purchasing an additional 451,450 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in shares of HealthEquity by 2.5% in the third quarter. Dimensional Fund Advisors LP now owns 1,559,008 shares of the company’s stock valued at $147,751,000 after purchasing an additional 38,154 shares during the period. Hedge funds and other institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of several analyst reports. KeyCorp upped their price target on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, January 8th. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Barrington Research dropped their price objective on shares of HealthEquity from $125.00 to $110.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 18th. Royal Bank Of Canada cut their price objective on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research report on Wednesday, March 18th. Finally, Barclays reduced their target price on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $110.36.

HealthEquity Stock Performance

Shares of HQY stock opened at $83.57 on Wednesday. The company has a current ratio of 3.27, a quick ratio of 3.27 and a debt-to-equity ratio of 0.45. The stock has a 50 day simple moving average of $79.95 and a 200-day simple moving average of $89.52. The company has a market cap of $7.06 billion, a price-to-earnings ratio of 33.97, a price-to-earnings-growth ratio of 1.48 and a beta of 0.26. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a return on equity of 13.86% and a net margin of 16.39%.The firm had revenue of $334.59 million for the quarter, compared to the consensus estimate of $332.48 million. HealthEquity’s revenue for the quarter was up 7.3% on a year-over-year basis. On average, equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.